Literature DB >> 12054526

Aspirin potently inhibits oxidative DNA strand breaks: implications for cancer chemoprevention.

C Susan Hsu1, Yunbo Li.   

Abstract

Epidemiological studies have suggested that the use of aspirin is associated with a decreased incidence of human malignancies, particularly colorectal cancer. Since reactive oxygen species (ROS) are critically involved in multistage carcinogenesis, this study was undertaken to examine the ability of aspirin to inhibit ROS-mediated DNA damage. Hydrogen peroxide (H2O2)+Cu(II) and hydroquinone (HQ) + Cu(II) were used to cause oxidative DNA strand breaks in phiX-174 plasmid DNA. We demonstrated that the presence of aspirin at concentrations (0.5-2 mM) compatible with amounts in plasma during chronic anti-inflammatory therapy resulted in a marked inhibition of oxidative DNA damage induced by either H2O2/Cu(II) or HQ/Cu(II). The inhibition of oxidative DNA damage by aspirin was exhibited in a concentration-dependent manner. Moreover, aspirin was found to be much more potent than the hydroxyl radical scavengers, mannitol and dimethyl sulfoxide, in protecting against the H2O2/Cu(II)-mediated DNA strand breaks. Since the reduction of Cu(II) to Cu(I) is crucially involved in both H2O2/Cu(II)- and HQ/Cu(II)-mediated formation of hydroxyl radical or its equivalent, and the subsequent oxidative DNA damage, we examined whether aspirin could inhibit this Cu(II)/Cu(I) redox cycle. It was observed that aspirin at concentrations that showed the inhibitory effect on oxidative DNA damage did not alter the Cu(II)/Cu(I) redox cycle in either H2O2/Cu(II) or HQ/Cu(II) system. In addition, aspirin was not found to significantly scavenge H2O2. This study demonstrates for the first time that aspirin potently inhibits both H2O2/Cu(II)- and HQ/Cu(II)-mediated oxidative DNA strand breaks most likely through scavenging the hydroxyl radical or its equivalent derived from these two systems. The potent inhibition of oxidative DNA damage by aspirin may thus partially contribute to its anticancer activities observed in humans. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054526     DOI: 10.1016/S0006-291X(02)00271-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Modulation by aspirin and naproxen of nucleotide alterations and tumors in the lung of mice exposed to environmental cigarette smoke since birth.

Authors:  Sebastiano La Maestra; Francesco D'Agostini; Alberto Izzotti; Rosanna T Micale; Luca Mastracci; Anna Camoirano; Roumen Balansky; James E Trosko; Vernon E Steele; Silvio De Flora
Journal:  Carcinogenesis       Date:  2015-10-13       Impact factor: 4.944

2.  EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin.

Authors:  Nathan Vandjelovic; Hong Zhu; Hara P Misra; Ryan P Zimmerman; Zhenquan Jia; Yunbo Li
Journal:  Mol Cell Biochem       Date:  2011-12-30       Impact factor: 3.396

3.  Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study.

Authors:  Anna E Prizment; Aaron R Folsom; Kristin E Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

4.  Graphene Quantum Dots Protect against Copper Redox-Mediated Free Radical Generation and Cardiac Cell Injury.

Authors:  Y Robert Li; Arben Santo; Hong Zhu; Zhenquan Jia; Michael A Trush
Journal:  React Oxyg Species (Apex)       Date:  2018-09

5.  Ethyl pyruvate inhibits peroxynitrite-induced DNA damage and hydroxyl radical generation: implications for neuroprotection.

Authors:  Wei Chen; Zhenquan Jia; Hong Zhu; Kequan Zhou; Yunbo Li; Hara P Misra
Journal:  Neurochem Res       Date:  2009-09-19       Impact factor: 3.996

6.  Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).

Authors:  Veronika Fedirko; Patrick T Bradshaw; Jane C Figueiredo; Robert S Sandler; Elizabeth L Barry; Dennis J Ahnen; Ginger L Milne; Robert S Bresalier; John A Baron
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-24

7.  Chronic Mild Hyperhomocysteinemia Alters Inflammatory and Oxidative/Nitrative Status and Causes Protein/DNA Damage, as well as Ultrastructural Changes in Cerebral Cortex: Is Acetylsalicylic Acid Neuroprotective?

Authors:  Daniella de S Moreira; Paula W Figueiró; Cassiana Siebert; Caroline A Prezzi; Francieli Rohden; Fatima C R Guma; Vanusa Manfredini; Angela T S Wyse
Journal:  Neurotox Res       Date:  2017-12-14       Impact factor: 3.911

Review 8.  Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer.

Authors:  Carmine Stolfi; Veronica De Simone; Francesco Pallone; Giovanni Monteleone
Journal:  Int J Mol Sci       Date:  2013-09-03       Impact factor: 5.923

Review 9.  Genome-Protecting Compounds as Potential Geroprotectors.

Authors:  Ekaterina Proshkina; Mikhail Shaposhnikov; Alexey Moskalev
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

10.  Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.

Authors:  Khong Bee Kang; Congju Zhu; Sook Kwin Yong; Qiuhan Gao; Meng Cheong Wong
Journal:  Mol Cancer       Date:  2009-08-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.